Pathophysiology of systemic sclerosis

被引:12
|
作者
Allanore, Yannick [1 ]
机构
[1] Univ Paris 05, Hop Cochin, Inst Cochin, INSERM,Rhumatol A,U1016, 27 Rue Faubourg St Jacques, F-75014 Paris, France
来源
M S-MEDECINE SCIENCES | 2016年 / 32卷 / 02期
关键词
PULMONARY ARTERIAL-HYPERTENSION; EXPERIMENTAL FIBROSIS; TOPOISOMERASE-I; DOWN-REGULATION; LUNG FIBROSIS; EXPRESSION; SKIN; AUTOIMMUNITY; ASSOCIATION; SCLERODERMA;
D O I
10.1051/medsci/20163202012
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Systemic sclerosis (SSc) is an orphan disease affecting the connective tissue. The cause of SSc remains unknown but is likely to involve environmental factors in a genetically primed individual with SSc belonging to the multigenic disorders. Pathogenesis is dominated by early microvascular changes targeting endothelial cells and with the release of several mediators promoting an inflammatory response and vascular remodelling. Several lines of evidence position autoimmunity as a key perpetuating event with activation of both innate and adaptive immunity and with the production of distinct autoantibodies. The cascade ultimates with the fibrosis defined by accumulation of extra-cellular matrix through an imbalance between synthesis and degradation of several components and mesenchymal cell activation and differentiation controlled by a large number of autocrine and paracrine factors.
引用
收藏
页码:183 / 191
页数:9
相关论文
共 50 条
  • [21] Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma)
    Sallam, H
    McNearney, TA
    Chen, JDZ
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (06) : 691 - 712
  • [22] Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis
    Sunderkoetter, C.
    Riemekasten, G.
    RHEUMATOLOGY, 2006, 45 : 33 - 35
  • [23] Pathophysiology and recent findings of primary biliary cirrhosis complicated by systemic sclerosis
    Ohira, Hiromasa
    Watanabe, Hiroshi
    HEPATOLOGY RESEARCH, 2014, 44 (04) : 377 - 383
  • [24] Cardiovascular Manifestations of Systemic Sclerosis: An Overview of Pathophysiology, Screening Modalities, and Treatment Options
    Lee, Kyu-In
    Manuntag, Levy Jo
    Kifayat, Alina
    Manuntag, Samantha Eugene
    Sperber, Kirk
    Ash, Julia Yegudin
    Frishman, William H.
    Wasserman, Amy
    CARDIOLOGY IN REVIEW, 2023, 31 (01) : 22 - 27
  • [25] Systemic sclerosis and erectile dysfunction: pathophysiology and PDE5-I treatment
    Garcia Escuder, A.
    Amaya Gutierrez, J.
    Martinez Kuiz, K.
    Romero Roncel, G.
    Garcia Perez, M.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2005, 28 : 51 - 51
  • [26] Chronic Graft-Versus-Host Disease and Systemic Sclerosis: The Same Pathophysiology?
    Parkman, Robertson
    Shah, Ami J.
    Masinsin, Bernadette
    Kapoor, Neena
    Abdel-Azim, Hisham
    Reiff, Andreas
    BLOOD, 2011, 118 (21) : 1740 - 1741
  • [27] The Origin of the Myofibroblast in Fibroproliferative Vasculopathy: Does the Endothelial Cell Steer the Pathophysiology of Systemic Sclerosis?
    Manetti, Mirko
    Guiducci, Serena
    Matucci-Cerinic, Marco
    ARTHRITIS AND RHEUMATISM, 2011, 63 (08): : 2164 - 2167
  • [28] Novel fibrogenic pathways are activated in response to endothelial apoptosis:: Implications in the pathophysiology of systemic sclerosis
    Laplante, P
    Raymond, MA
    Gagnon, G
    Vigneault, N
    Sasseville, AMJ
    Langelier, Y
    Bernard, M
    Raymond, Y
    Hébert, MJ
    JOURNAL OF IMMUNOLOGY, 2005, 174 (09): : 5740 - 5749
  • [29] The pathophysiology of multiple sclerosis
    Bogumil, T
    NERVENHEILKUNDE, 2000, 19 (06) : 291 - 294
  • [30] Author Correction: Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management
    Zsuzsanna H. McMahan
    Subhash Kulkarni
    Joan Chen
    Jiande Z. Chen
    Ramnik J. Xavier
    P. Jay Pasricha
    Dinesh Khanna
    Nature Reviews Rheumatology, 2023, 19 : 191 - 191